Horan Capital Advisors, Llc. Eli Lilly & CO Transaction History
Horan Capital Advisors, Llc.
- $294 Million
- Q4 2024
A detailed history of Horan Capital Advisors, Llc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Horan Capital Advisors, Llc. holds 750 shares of LLY stock, worth $676,350. This represents 0.2% of its overall portfolio holdings.
Number of Shares
750
Previous 750
-0.0%
Holding current value
$676,350
Previous $664,000
12.8%
% of portfolio
0.2%
Previous 0.22%
Shares
11 transactions
Others Institutions Holding LLY
# of Institutions
4,270Shares Held
757MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$87.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$67 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$46.3 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$30.9 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $857B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...